Japan· JP-3929007F1037
酢酸亜鉛水和物
A medicinal product containing 酢酸亜鉛水和物, registered in Japan by 沢井製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 酢酸亜鉛水和物
- Manufacturer
- 沢井製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
酢酸亜鉛水和物 in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States(Re) Setting 100% mineral Powder Deep Broad Spectrum SPF 35Supergoop, LLC
- GermanyBiolectraHermes Arzneimittel Gmbh
- United KingdomAntipeol ointmentAspar Pharmaceuticals Ltd
- BelgiumAlopateCeres Pharmaceuticals
- NetherlandsWilzin 25 mg, harde capsulesOrphan Europe SARL
- PolandMaść cynkowaHerbapol - Poznańskie Zakłady Zielarskie S.A.
- FranceEFFIZINC 15 mg, géluleEXPANSCIENCE
- FinlandVetzin vet.Vepidan Aps
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Labisan, Zink Aguettant
- Belgium · Unguentum, Zinc Aguettant
- Germany · Biolectra, Cefazink
- Denmark · Zipzoc
- Spain · Pasta Lassar Imba
- Finland · Zipzoc
- France · Effizinc, Oligosol
- United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
- Greece · Zincalto, Zinctin
- Ireland · Caldease, Zinc Ovelle
- Iceland · Wilzin
- Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
- Liechtenstein · Wilzin
- Luxembourg · Cefazink, Oligosol
- Latvia · Cinka Rff
- Netherlands · Daro Zinkzalf, Zinkolie
- Norway · Wilzin
- Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
- Portugal · Halibut, Lassadermil
- Sweden · Zipzoc
- Slovakia · Tekutý Púder
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0f362a5e-5a42-47ab-b794-76ffb8b9022a GET /v1/drugs/0f362a5e-5a42-47ab-b794-76ffb8b9022a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3929007F1037",
"category": "内用薬",
"price_yen": 81.5,
"generic_name": "酢酸亜鉛水和物",
"product_name_jp": null,
"therapeutic_class": "3929",
"transitional_expiry": null
}See everything about 酢酸亜鉛水和物.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.